Lars Henrikson
Director/Board Member bei XVIVO PERFUSION AB
Vermögen: 33 434 $ am 31.03.2024
Profil
Lars Henrikson is currently the Director at Xvivo Perfusion AB and also holds a Director position at AddBIO AB.
He previously held the position of Vice President-Marketing & Business Development at Dentsply IH, Inc. and Wellspect HealthCare AB.
He was also the Executive Vice President at Wellspect AG and Dentsply Sweden AB.
Mr. Henrikson holds a doctorate degree from the University of Gothenburg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XVIVO PERFUSION AB
0,00% | 24.04.2023 | 1 300 ( 0,00% ) | 33 434 $ | 31.03.2024 |
Aktive Positionen von Lars Henrikson
| Unternehmen | Position | Beginn |
|---|---|---|
| XVIVO PERFUSION AB | Director/Board Member | 01.01.2020 |
Dentsply IH, Inc.
 Dentsply IH, Inc. Medical SpecialtiesHealth Technology Dentsply IH, Inc. provides medical devices for dentistry and urology. It develops, manufactures, and markets healthcare devices for single use and medical implants. The company was founded in 1948 and is headquartered in Waltham, MA. | Sales & Marketing | - |
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Director/Board Member | - |
Ehemalige bekannte Positionen von Lars Henrikson
| Unternehmen | Position | Ende |
|---|---|---|
Wellspect HealthCare AB
 Wellspect HealthCare AB Medical SpecialtiesHealth Technology Wellspect HealthCare AB develops, manufactures, and markets dental, urological, surgical, and medical products. Its products include LoFric Primo, LoFric Plus, LoFric Cath-Kit, LoFric Hydro-Kit II, and LoFric Dila-Cath. The company was founded in 1948 and is headquartered in Molndal, Sweden.. | Sales & Marketing | 31.07.2018 |
Wellspect AG
 Wellspect AG Medical SpecialtiesHealth Technology Part of Dentsply Sirona, Inc., Wellspect AG is a Swedish company that manufactures dental implants. The private company is based in Malmö, Sweden. Wellspect was acquired by Wellspect HealthCare AB, part of Dentsply Sirona, Inc. from August 31, 2011 on July 01, 2005. | Corporate Officer/Principal | - |
| Dentsply Sweden AB | Corporate Officer/Principal | - |
Ausbildung von Lars Henrikson
| University of Gothenburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| XVIVO PERFUSION AB | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Dentsply IH, Inc.
Dentsply IH, Inc. Medical SpecialtiesHealth Technology Dentsply IH, Inc. provides medical devices for dentistry and urology. It develops, manufactures, and markets healthcare devices for single use and medical implants. The company was founded in 1948 and is headquartered in Waltham, MA. | Health Technology |
Wellspect HealthCare AB
Wellspect HealthCare AB Medical SpecialtiesHealth Technology Wellspect HealthCare AB develops, manufactures, and markets dental, urological, surgical, and medical products. Its products include LoFric Primo, LoFric Plus, LoFric Cath-Kit, LoFric Hydro-Kit II, and LoFric Dila-Cath. The company was founded in 1948 and is headquartered in Molndal, Sweden.. | Health Technology |
Wellspect AG
Wellspect AG Medical SpecialtiesHealth Technology Part of Dentsply Sirona, Inc., Wellspect AG is a Swedish company that manufactures dental implants. The private company is based in Malmö, Sweden. Wellspect was acquired by Wellspect HealthCare AB, part of Dentsply Sirona, Inc. from August 31, 2011 on July 01, 2005. | Health Technology |
AddBIO AB
AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
| Dentsply Sweden AB |
